Skip to main content

Peer Review reports

From: Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis

Original Submission
29 Nov 2023 Submitted Original manuscript
26 Dec 2023 Reviewed Reviewer Report
18 Jan 2024 Reviewed Reviewer Report
12 Mar 2024 Author responded Author comments - Yingjie Qi
14 Mar 2024 Author responded Author comments - Yingjie Qi
Resubmission - Version 2
12 Mar 2024 Submitted Manuscript version 2
25 Mar 2024 Reviewed Reviewer Report
29 Apr 2024 Reviewed Reviewer Report
6 May 2024 Author responded Author comments - Yingjie Qi
Resubmission - Version 3
6 May 2024 Submitted Manuscript version 3
Publishing
4 Jun 2024 Editorially accepted
8 Jun 2024 Article published 10.1186/s12885-024-12478-1

You can find further information about peer review here.

Back to article page